{"id":"W2593027991","doi":"10.1002/cncr.30657","title":"Quality of life with cediranib in relapsed ovarian cancer: The <scp>ICON</scp>6 phase 3 randomized clinical trial","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; AstraZeneca","keywords":"Medicine; Internal medicine; Chemotherapy; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Randomization; Clinical trial; Oncology; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002765188,0.0002452913,0.001666602,0.00005366412,0.0001658595,0.00004700678,0.0002840186,0.0001687442,0.0002669477],"category_scores_gemma":[0.002792032,0.0001348337,0.0003861986,0.000111557,0.0006408289,0.00007560088,0.00004961664,0.0003679238,0.000006736454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001860901,"about_ca_system_score_gemma":0.001385577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006560265,"about_ca_topic_score_gemma":0.002323724,"domain_scores_codex":[0.997174,0.0005188755,0.001101495,0.0004699373,0.0004112328,0.0003244285],"domain_scores_gemma":[0.9957066,0.001798838,0.0009796153,0.001105421,0.0001709747,0.0002386065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7209093,0.002841872,0.2170685,0.0001882185,0.002207791,0.00006717996,0.001188878,0.00002445009,0.00006979584,0.002232035,0.007550743,0.04565126],"study_design_scores_gemma":[0.9042488,0.0007018393,0.08685276,0.0003391548,0.0005968834,0.000001208564,0.0001104081,0.00009614501,0.0002765765,0.0001196091,0.006586119,0.0000705219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806135,0.003252808,0.0000463265,0.00751995,0.001537221,0.00290024,0.0001080227,0.00002505454,0.003996922],"genre_scores_gemma":[0.9921045,0.003229017,0.000112105,0.001106357,0.00132074,0.001446007,0.000009656958,0.00003270166,0.0006389284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1833395,"threshold_uncertainty_score":0.9917201,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1166912492270821,"score_gpt":0.4506985208661173,"score_spread":0.3340072716390352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}